Home Stocks TransCode Therapeutics, Inc. Shareholders TransCode Therapeutics, Inc. · BOATS:RNAZ
TransCode Therapeutics, Inc. shareholders As of Sep 30, 2026, 12 institutions reported holding TransCode Therapeutics, Inc., 0.58% of its shares. Largest: Yorkville Advisors Global, LP, Citadel and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
Shareholders Institutions Holder Shares Of the company Value As of Yorkville Advisors Global, LP 75,786 0.44% US$127K Sep 30, 2026 Citadel 10,207 0.06% US$17,148 Sep 30, 2026 Vanguard 9,527 0.06% US$16,006 Sep 30, 2026 UBS 2,650 0.02% US$4,452 Sep 30, 2026 Tower Research Capital LLC (TRC) 1,746 0.01% US$2,934 Sep 30, 2026 Osaic Holdings, Inc. 270 <0.01% US$453 Sep 30, 2026 Robinhood Markets, Inc. 102 <0.01% US$168 Sep 30, 2026 Wells Fargo 55 <0.01% US$92 Sep 30, 2026 SBI Securities Co., Ltd. 12 <0.01% US$20 Sep 30, 2026 Fidelity 11 <0.01% US$18 Sep 30, 2026 IFP Advisors, Inc 8 <0.01% US$13 Sep 30, 2026 Northwestern Mutual Wealth Management Co 1 <0.01% US$2 Sep 30, 2026
Funds Holder Shares Of the company Value As of Fidelity Extended Market Index Fund 8,492 0.05% US$43,649 May 31, 2026 Vanguard Extended Market Index Fund 6,545 0.04% US$40,644 Jun 30, 2026 Fidelity Series Total Market Index Fund 1,180 <0.01% US$6,065 May 31, 2026 Fidelity Total Market Index Fund 510 <0.01% US$2,621 May 31, 2026